Humacyte, Inc. (HUMA) Tops Q1 EPS by 3c

Humacyte, Inc. (NASDAQ: HUMA) reported Q1 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $2.09 million.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
• Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'
• Canaan mined 64 BTC in June, holds record 1,915 BTC on balance sheet